B. Nankivell and S. Alexander, Rejection of the kidney allograft, N Engl J Med, vol.363, issue.15, pp.1451-1462, 2010.

J. Sellarés, D. De-freitas, and M. Mengel, Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence, American Journal of Transplantation, vol.10, issue.2, pp.388-399, 2012.
DOI : 10.1111/j.1600-6143.2011.03840.x

E. Pouliquen, A. Koenig, and C. Chen, Recent advances in renal transplantation: antibody-mediated rejection takes center stage, F1000Prime Reports, vol.7, issue.7, p.51, 2015.
DOI : 10.12703/P7-51

T. Fehr and A. Gaspert, Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale, Transplant International, vol.7, issue.Suppl. 3, pp.623-655, 2012.
DOI : 10.1111/j.1432-2277.2012.01453.x

R. Sapir-pichhadze, S. Curran, and R. John, A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection, Kidney International, vol.87, issue.1, pp.182-194, 2015.
DOI : 10.1038/ki.2014.166

A. Loupy, G. Hill, and S. Jordan, The impact of donor-specific anti-HLA antibodies on late kidney allograft failure, Nature Reviews Nephrology, vol.11, issue.6, pp.348-357, 2012.
DOI : 10.1038/nrneph.2012.81

A. Djamali, D. Kaufman, and T. Ellis, Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches, American Journal of Transplantation, vol.2012, issue.5 Pt 1, pp.255-271, 2014.
DOI : 10.1111/ajt.12589

A. Konvalinka and K. Tinckam, Utility of HLA Antibody Testing in Kidney Transplantation, Journal of the American Society of Nephrology, vol.26, issue.7, pp.1489-1502, 2015.
DOI : 10.1681/ASN.2014080837

M. Haas, B. Sis, and L. Racusen, Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions, American Journal of Transplantation, vol.17, issue.2, pp.272-283, 2014.
DOI : 10.1111/ajt.12590

T. Kobayashi, E. Maruya, and M. Niwa, Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation, Human Immunology, vol.72, issue.1
DOI : 10.1016/j.humimm.2010.10.018

L. Croze, R. Tetaz, and M. Roustit, donor-specific antibodies, Transplant International, vol.6, issue.8 Suppl, pp.775-783, 2014.
DOI : 10.1111/tri.12330

R. Heilman, A. Nijim, and Y. Desmarteau, De Novo Donor-Specific Human Leukocyte Antigen Antibodies Early After Kidney Transplantation, Transplantation, vol.98, issue.12, pp.1310-1315, 2014.
DOI : 10.1097/TP.0000000000000216

C. Lefaucheur, A. Loupy, and G. Hill, Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation, Journal of the American Society of Nephrology, vol.21, issue.8, pp.1398-1406, 2010.
DOI : 10.1681/ASN.2009101065

D. Kannabhiran, J. Lee, and J. Schwartz, Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure, Transplantation, vol.99, issue.6, pp.1156-1164, 2015.
DOI : 10.1097/TP.0000000000000511

G. Guidicelli, G. Anies, and T. Bachelet, The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients, Transplant Immunology, vol.29, issue.1-4, pp.1-417, 2013.
DOI : 10.1016/j.trim.2013.09.005

E. Schwaiger, M. Wahrmann, and G. Bond, Complement Component C3 Activation, Transplantation, vol.97, issue.12
DOI : 10.1097/01.TP.0000441091.47464.c6

M. Schnaidt, C. Weinstock, and M. Jurisic, HLA Antibody Specification Using Single-Antigen Beads???A Technical Solution for the Prozone Effect, Transplantation, vol.92, issue.5, pp.510-515, 2011.
DOI : 10.1097/TP.0b013e31822872dd

M. Stegall, M. Chedid, and L. Cornell, The role of complement in antibody-mediated rejection in kidney transplantation, Nature Reviews Nephrology, vol.11, issue.11, pp.670-678, 2012.
DOI : 10.1038/nrneph.2012.212

C. Lefaucheur, D. Nochy, and G. Hill, Determinants of Poor Graft Outcome in Patients with Antibody-Mediated Acute Rejection, American Journal of Transplantation, vol.10, issue.1, pp.832-841, 2007.
DOI : 10.1034/j.1600-6143.2001.001003260.x

A. Loupy, G. Hill, and C. Suberbielle, Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor-Specific Antibodies (DSA), American Journal of Transplantation, vol.89, issue.1, pp.56-65, 2011.
DOI : 10.1111/j.1600-6143.2010.03364.x

A. Loupy, C. Lefaucheur, and D. Vernerey, Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival, New England Journal of Medicine, vol.369, issue.13, pp.1215-1226, 2013.
DOI : 10.1056/NEJMoa1302506

S. Llorente, F. Boix, and J. Eguia, C1q-Fixing Human Leukocyte Antigen Assay in Immunized Renal Patients: Correlation Between Luminex SAB-C1q and SAB-IgG, Transplantation Proceedings, vol.44, issue.9, pp.2535-2537, 2012.
DOI : 10.1016/j.transproceed.2012.09.084

G. Chen, F. Sequeira, and D. Tyan, Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads, Human Immunology, vol.72, issue.10
DOI : 10.1016/j.humimm.2011.07.001

M. Messina, C. Ariaudo, P. Barbato, and L. , Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy, Transplant Immunology, vol.33, issue.1, pp.7-12, 2015.
DOI : 10.1016/j.trim.2015.06.002

M. Yell, B. Muth, and D. Kaufman, C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection, Transplantation, vol.99, issue.6, pp.1151-1155, 2015.
DOI : 10.1097/TP.0000000000000699

P. Ata, M. Canbakan, and M. Kara, Serum Flow Cytometric C1q Binding Antibody Analysis of Renal Recipients with Low Levels of Sensitization, Transplantation Proceedings, vol.44, issue.6, pp.1652-1655, 2012.
DOI : 10.1016/j.transproceed.2012.05.032

S. Calp-inal, M. Ajaimy, and M. Melamed, The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation, Kidney International, vol.89, issue.1, pp.209-216, 2015.
DOI : 10.1038/ki.2015.275

G. Guidicelli, F. Guerville, and S. Lepreux, Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival, Journal of the American Society of Nephrology, vol.27, issue.2, pp.615-625, 2016.
DOI : 10.1681/ASN.2014040326

A. Sicard, S. Ducreux, and M. Rabeyrin, Detection of C3d-Binding Donor-Specific Anti-HLA Antibodies at Diagnosis of Humoral Rejection Predicts Renal Graft Loss, Journal of the American Society of Nephrology, vol.26, issue.2, pp.457-467, 2015.
DOI : 10.1681/ASN.2013101144

A. Tambur, N. Herrera, and K. Haarberg, Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information, American Journal of Transplantation, vol.343, issue.9, pp.2421-2430, 2015.
DOI : 10.1111/ajt.13295